Page 4 - ஜப்பானிய அமைச்சகம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amgen Reports Second Quarter 2021 Financial Results Amgen today announced financial results for the second quarter of 2021. Key results include: Total revenues increased 5% to $6.5 billion in comparison to the second quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices. Product sales increased 3% globally, driven by double digit volume growth across a number of our products including Prolia ® Repatha ® and our biosimilar … – Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2021. Key results include: Total revenues increased 5% to $6.5 billion in comparison to the second quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices.

Puerto ricoUnited statesNorth carolinaNeulasta onproTrish rowlandRoberta bradwayEli lillyProvention bioEuropean society for medical oncology congressXencor incResearch developmentTherapeutics incNational comprehensive cancer networkRegeneron pharmaceuticals incCompany lillyEuropean commission